Funder: National Institutes of Health (NIH)
Due Dates: August 19, 2026 (estimated, forecasted)
Funding Amounts: ~$8,000,000 total program funding | Expected 2 awards | Cooperative Agreement
Summary: Supports multidisciplinary research to accelerate hepatitis B cure in persons living with HIV and HBV, focusing on mechanisms, biomarkers, drug targets, and non-invasive diagnostics.
Key Information: Forecasted opportunity; final details may change.